Abstracts (HTML) List of Authors

Sabbah, M

Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells

Sacco, C

Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.

Sachs, L

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer

Saeedi, SS

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation

Saeedi Saravi, SS

Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota

Säemann, M

Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm

Saith, SE

Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System

Sanabria, F

An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database

Sangalli-Baruffaldi, J

Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises

Santoro, C

A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A

Santos, S

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII

Sauer, T

A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)

Saultier, P

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Saut, N

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Savoia, A

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Sawyer, EK

AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years

Schaller, M

Upregulated autophagy in antigen-presenting splenic cells hints at promotion of immune-mediated thrombotic thrombocytopenic purpura (iTTP)

Scharf, R

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone

Schellong, S

Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany

Schelzig, H

Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression

Schlag, R

Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue

Schlagenhauf, A

The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes

Schmaldienst, S

Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm

Schmidt, A

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Schmidt-Supprian, M

Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection

Schmitt, C

Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors

Schmoldt, D

smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patients

Schneider, H

Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia

Schneppenheim, R

Characterization of activity and cleavage of von Willebrand disease type 2B variants

Schneppenheim, S

Characterization of activity and cleavage of von Willebrand disease type 2B variants

Schoenichen, C

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Schoergenhofer, C

Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader

Schön, I

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation

Schön, K

Characterization of rFIX fusion proteins enabling subcutaneous administration

Schörgenhofer, C

Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study

Schramm, T

Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia

Schröder, G

Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B

Schulte, J

Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.

Schutgens, R

AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years

Schüttrumpf, J

The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy

Schwaeble, J

AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years

Schwameis, M

Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study

Schwartz, B

Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency

Schwarz, N

Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway

Sebastian, T

The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.

Seifert, W

Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen

Seifried, E

AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years

Sergentanis, T

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Seri, M

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients

Severin, K

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication

Seyfert-Brandt, W

Characterization of rFIX fusion proteins enabling subcutaneous administration

Shahzad, K

Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury

Shang, A

An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database

Shanmukhaiah, C

Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors

Shi, HP

Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study

Siddiqui, F

A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Hepatic Disorders Contribute to Platelet Dysfunction

Siegemund, A

Application of the STG-Bleedscreen assay in clinical routine
Enhanced prothrombotic state in patients with severe COVID-19

Siegemund, T

Application of the STG-Bleedscreen assay in clinical routine
Enhanced prothrombotic state in patients with severe COVID-19

Sigmund, M

Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System

Simoncini, D

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Singh, K

LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation

Sinkovits, G

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients

Sinn, M

LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry

Skoumalova, A

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT

Slavik, L

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?

Slavík, L

The occurrence of trombocythopathy in CLL patients treated with Ibrutinib

SMontague, S

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Sobotta, F

Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability

Soehnlein, O

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Solomon, C

Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency

Sommerer, P

A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A

Souza, FD

Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency

Spannagl, M

A novel approach to laboratory assessment of platelet von Willebrand factor

Spiel, A

Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader

Stark-Lorenzen, P

Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue

Starostka, D

The occurrence of trombocythopathy in CLL patients treated with Ibrutinib

Stauch, M

Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue

Staudinger, T

Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation

Steffen, F

Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.

Stepan, H

LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation

Studt, JD

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Sussebach, C

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Szathmáry, B

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients

Szlávik, J

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients